Category Archives: Health Care

Understanding Child Trauma (Spanish Version)

Este folleto enseña a los padres y cuidadores sobre los tipos de estrés traumático en los jóvenes. Explica el impacto que pueden tener los eventos traumáticos en la salud física y psicológica, e incluye una lista de recursos para ayudar con la recuperación. Inventory#: SMA17-4923

The Way Forward: Federal Action for a System That Works for All People Living With SMI and SED and Their Families and Caregivers – Executive Summary

PREORDER: This publication is currently backordered but will be sent to you as soon as it becomes available.

This Executive Summary to the 2017 report to Congress shines the spotlight on the critical issues and services for Americans with serious mental illnesses (SMI) and serious emotional disturbances (SED). The 2017 report to congress represents the starting point in a five-year process of improving the lives of people with SMI and SED. This 8-page summary delineates the five focus areas, each with 8-10 recommendations. These recommendations are from the non-federal members and represent common areas in which federal partners and stakeholders can work together to implement over the next five years.
Inventory#: PEP17-ISMICC-RTC-ES

The Way Forward: Federal Action for a System That Works for All People Living With SMI and SED and Their Families and Caregivers – Full Report

PREORDER: This publication is currently backordered but will be sent to you as soon as it becomes available.

This 2017 report to Congress shines the spotlight on the critical issues and services for Americans with serious mental illnesses (SMI) and serious emotional disturbances (SED). The report represents the starting point in a five-year process of improving the lives of people with SMI and SED. This report has five focus areas each with 8-10 recommendations. These recommendations are from the non-federal members and represent common areas in which federal partners and stakeholders can work together to implement over the next five years. Inventory#: PEP17-ISMICC-RTC

Rx Pain Medications, Know the Options, Get the Facts

The Rx Pain Medications. Know the Options. Get the Facts. is a series of 13 fact sheets designed to increase awareness of the risks associated with prescription opioid use and misuse, as well as to educate patients who are prescribed opioids for pain about the risks and to provide resources on methods for alternative pain management. This particular fact sheet focuses on patients requiring assistance with ineffective medications. Inventory#: SMA17-5053-4

Rx Pain Medications, Know the Options, Get the Facts:

The Rx Pain Medications. Know the Options. Get the Facts. is a series of 13 fact sheets designed to increase awareness of the risks associated with prescription opioid use and misuse, as well as to educate patients who are prescribed opioids for pain about the risks and to provide resources on methods for alternative pain management. This particular fact sheet focuses on the importance of properly storing medication in the home to avoid accidental ingestion by children. Inventory#: SMA17-5053-11

Rx Pain Medications, Know the Options, Get the Facts:

The Rx Pain Medications. Know the Options. Get the Facts. is a series of 13 fact sheets designed to increase awareness of the risks associated with prescription opioid use and misuse, as well as to educate patients who are prescribed opioids for pain about the risks and to provide resources on methods for alternative pain management. This particular fact sheet focuses on using Naloxone as a deterrent to overdose. Inventory#: SMA17-5053-13

Rx Pain Medications, Know the Options, Get the Facts:

The Rx Pain Medications. Know the Options. Get the Facts. is a series of 13 fact sheets designed to increase awareness of the risks associated with prescription opioid use and misuse, as well as to educate patients who are prescribed opioids for pain about the risks and to provide resources on methods for alternative pain management. This particular fact sheet focuses on how clinicians can discuss the appropriate use of opioids, dosage, and the dangers of opioid use disorder and overdose. Inventory#: SMA17-5053-9

Rx Pain Medications, Know the Options, Get the Facts:

The Rx Pain Medications. Know the Options. Get the Facts. is a series of 13 fact sheets designed to increase awareness of the risks associated with prescription opioid use and misuse, as well as to educate patients who are prescribed opioids for pain about the risks and to provide resources on methods for alternative pain management. This particular fact sheet focuses on the side effects and interactions of pain medication including opioid use disorder and overdose. Inventory#: SMA17-5053-3

Rx Pain Medications, Know the Options, Get the Facts:

The Rx Pain Medications. Know the Options. Get the Facts. is a series of 13 fact sheets designed to increase awareness of the risks associated with prescription opioid use and misuse, as well as to educate patients who are prescribed opioids for pain about the risks and to provide resources on methods for alternative pain management. This particular fact sheet focuses on the prescription pain medication agreement. Inventory#: SMA17-5053-6

Rx Pain Medications, Know the Options, Get the Facts:

The Rx Pain Medications. Know the Options. Get the Facts. is a series of 13 fact sheets designed to increase awareness of the risks associated with prescription opioid use and misuse, as well as to educate patients who are prescribed opioids for pain about the risks and to provide resources on methods for alternative pain management. This particular fact sheet focuses on how Prescription Drug Monitoring Programs (PDMPs) help health providers better serve their patients’ needs and promote safety. Inventory#: SMA17-5053-8

U.S. District Court Rules in FTC’s Favor, Imposes $40 Million Judgment Against Weight-Loss Supplement Marketers for Order Violations

 A federal district judge in Atlanta has issued an order finding several defendants, including repeat offender Jared Wheat, in contempt for violating previous court orders related to the sale of weight-loss dietary supplements. The order imposes a more than $40 million judgment against the defendants, part or all of which the Federal Trade Commission may use to provide refunds to deceived consumers who bought the products.

Gadget Island, Inc. dba Gear Isle Issues Voluntary Nationwide Recall of Rhino 7 Platinum 5000, Papa Zen 3300, Fifty Shades 6000 and Grande X 5800, Due to Presence of Undeclared Sildenafil, Tadalafil and Desmethyl Carbodenafil

Newark, CA, Gadget Island, Inc. is voluntarily recalling Rhino 7 Platinum 5000 capsules, All LOTS, Papa Zen 3300 capsules, LOT# NSS050888, Fifty Shades 6000 capsules, all Lots, Grande X 5800 capsules, all Lots, to the consumer level. FDA analysis has found the products to be tainted with Sildenafil and Tadalafil, which are the active ingredients in two FDA-approved prescription drugs used for the treatment of erectile dysfunction (ED), as well as Desmethyl Carbodenafil which is structurally similar to sildenafil.

Kiriko, LLC. Issues Voluntary Nationwide Recall of A1 Slim Due to Undeclared Sibutramine, Phenolphthalein and N-Desmethyl sibutramine

Kiriko, LLC. is voluntarily recalling all lots of A1 Slim 30 capsules bottle to the consumer level.  FDA laboratory analysis has found the A1 Slim product to be tainted with sibutramine, phenolphthalein and N-Desmethyl sibutramine. 

These undeclared ingredients make this product an unapproved new drug for which safety and efficacy have not been established; therefore, subject to recall.

Welcoming New Projects and Partners to Address Pain in the Military Population

I am proud to announce NIH’s newest interagency research initiative on pain management in military service members and veterans. 

NCCIH, lead for this multi-agency initiative called the NIH-DoD-VA Pain Management Collaboratory, is contributing more than half the funding for these 12 projects to develop, implement, and test nondrug approaches for managing pain and its related conditions in the military and veteran population―including opioid misuse, abuse, and disorder. The total funding for this project will be $81 million over 6 years. 

Key Substance Use and Mental Health Indicators in the United States:

This report presents 2016 national estimates of use of alcohol, tobacco products, illicit drugs (such as, marijuana, cocaine, heroin, hallucinogens, and inhalants, as well as the misuse of opioids, prescription pain relievers, tranquilizers, stimulants, and sedatives), substance use disorders, and substance use treatment among people 12 years of age and older. It Includes national estimates of any mental illness, serious mental illness, major depressive episode, use of mental health services and suicidal ideation among adults ages 18 or older and national estimates of major depressive episode, use of mental health services among adolescents aged 12 to 17. Trend information on these topics are also presented. Inventory#: SMA17-5044